IL15 and metastatic melanoma: Notably, a powerful antitumor response leading to 100% survival for more than 300 days was seen in IL-15-treated mice infused with Rapa-T cells, while most of the mice receiving Rapa-T cells without IL-15 and half of the IL-15-treated mice receiving Ctrl-T cells succumbed to metastatic melanoma.